Artikkelit - Selaus nimekkeen mukaan
Viitteet 60-79 / 186
-
Fimea HTA-prosessin rakentajana
Farmasian päivät 2012 : Turvallista lääkehoitoa (Farmasian oppimiskeskus, 2012) -
Fimean tukimus- ja kehittämistoiminta - missä mennään?
Farmasia 2020 : ratkaisuja tulevaisuuteen (Farmasian oppimiskeskus, 2010) -
Food effects in paediatric medicines development for products Co-administered with food
International journal of pharmaceutics (Elsevier, 2018) -
Fourth graders' perceptions about medicines and medicine use
Health Education : 1 (2014)Purpose – The purpose of this paper is to contribute to the development of medicine education by examining pupils’ perceptions of medicines and medicine use. Design/methodology/approach – Fourth graders’ (n¼51, aged 10-11) ... -
General practitioners' attitudes towards electronic prescribing and the use of the national prescription centre
Journal of Evaluation in Clinical Practice : 5 (Blackwell Publishing, 01.10.2016)Rationale, aims and objectives: The purpose of this study was to assess general practitioners' (GP) experience of an electronic prescription (e-prescription) system and the use of a national prescription centre. Methods: ... -
Glargin - ja detemirinsuliinin hoidollinen ja taloudellinen arviointi
Farmasian päivät 2012 : Turvallista lääkehoitoa (Farmasian oppimiskeskus, 2012) -
HbA1c analytiikan ja yksikköjen tilanne Suomessa syksyllä 2016
Kliin lab : 5 (Suomen kliinisen kemian yhdistys, 2016) -
HbA1c-analytiikan tilanne Suomessa ja muualla maailmassa
Moodi : 3-4 (Kliinisten laboratoriotutkimusten laaduntarkkailu, 2016) -
HbA1c-analytiikka ja määritysmenetelmien laatu laaduntarkkailutulosten valossa
(Suomen kliinisen kemian yhdistys r.y.,, 2018) -
Health and medication literacy and the desire to participate in pharmacotherapy decision making : comparison of two countries
Research in Social and Administrative Pharmacy : 9 (Elsevier Inc., 09 / 2018) -
Hinta ohjaa oraalisen antikoagulantin valintaa eteisvärinäpotilaalle
Suomen Lääkärilehti : 34 (Suomen lääkäriliitto, 25.08.2017)Suorat oraaliset antikoagulantit ovat varfariinihoidon vaihtoehto eteisvärinäpotilaiden hoidossa. Näiden lääkkeiden välinen suuri hintaero kuitenkin ohjaa hoidon valintaa osalla potilaista, osoittaa haastattelututkimus, ... -
Hoidollinen arvo perustuu vertailevaan tutkimukseen
Suomen Lääkärilehti : 1-2 (Suomen Lääkäriliitto, 09.01.2015) -
Immunogenicity Assessment of Biosimilars
Pharmaceutical Medicine : 2 (Springer International Publishing, 06.04.2018) -
Impact of statin adherence on cardiovascular morbidity and all-cause mortality in the primary prevention of cardiovascular disease; A population-based cohort study in Finland
Value in Health : 6 (2015)Objectives: To assess the extent to which adherence to statins is associated with the incidence of cardiovascular(CV) events and all- cause mortality in the primary prevention of CV diseases and whether different ... -
Incorporating patient perspectives in health technology assessments and clinical practice guidelines
Research in Social and Administrative Pharmacy : 6 (Elsevier, 01.11.2016)Background Ensuring patient involvement in health technology assessments (HTAs) and clinical practice guidelines (CPGs) is important. However, the goals and methods of such involvement are not always clear. Objectives The ... -
Infektion jälkeiset oireyhtymät
Lääkärin käsikirja (Kustannus Oy Duodecim, 08 / 2021) -
Inflammasomes and SARS-CoV-2 Infection
Viruses : 12:2513 (Multidisciplinary Digital Publishing Institute, 12 / 2021) -
Information sources used by parents to learn about medications they are giving their children
Research of Social and Administrative Pharmacy (2012)Background: Previous studies have indicated the use of medication by children to be dependent on the attitudes of knowledge of their parents; however, little is known about sources parents might use in driving medication ... -
Interchangeability of Biosimilars : A European Perspective
BioDrugs : 2 (Springer International Publishing, 01.04.2017)Many of the best-selling ‘blockbuster’ biological medicinal products are, or will soon be, facing competition from similar biological medicinal products (biosimilars) in the EU. Biosimilarity is based on the comparability ...